bpc-157 human trial Frontiers bpc 157 human clinical trial

Researchers also study BPC-157 peptide in laboratory systems focused on tendons, muscles, joints, ligaments, and connective tissues

BPC-157s research base is anchored in the work of Sikiric and colleagues at the University of Zagreb, who have published extensively on the peptide since the early 1990s

For good reason: while high levels of folic acid have health risks of their own, low levels of vitamin B9 have been associated with cancer, stroke, heart disease, and birth defects

doi: 10.1038/d41586-022-00382-2 102 MontoyaJGKogelnikAMBhangooMLunnMRFlamandLMerrihewLEet al

The SURPASS trials showed A1c reductions of 1.24% to 2.58% depending on the dose and comparator